Jw Holdings
JW Holdings Corporation, together with its subsidiaries, operates as a healthcare company in South Korea, the United States, Japan, China, and internationally. The company offers amino acid solutions, gastrointestinal agents, wound care, eye care, liver disease treatment, cold medicine, API, oral and topical analgesic, and other miscellaneous pharmaceutical products. It also offers hairdye, hair … Read more
Jw Holdings (096760) - Net Assets
Latest net assets as of September 2025: ₩567.12 Billion KRW
Based on the latest financial reports, Jw Holdings (096760) has net assets worth ₩567.12 Billion KRW as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩1.23 Trillion) and total liabilities (₩662.18 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩567.12 Billion |
| % of Total Assets | 46.13% |
| Annual Growth Rate | 5.36% |
| 5-Year Change | 55.65% |
| 10-Year Change | 92.89% |
| Growth Volatility | 18.2 |
Jw Holdings - Net Assets Trend (2007–2024)
This chart illustrates how Jw Holdings's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Jw Holdings (2007–2024)
The table below shows the annual net assets of Jw Holdings from 2007 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ₩521.39 Billion | +49.50% |
| 2023-12-31 | ₩348.75 Billion | +4.65% |
| 2022-12-31 | ₩333.26 Billion | +9.33% |
| 2021-12-31 | ₩304.82 Billion | -9.00% |
| 2020-12-31 | ₩334.97 Billion | -4.73% |
| 2019-12-31 | ₩351.62 Billion | -12.31% |
| 2018-12-31 | ₩401.00 Billion | +7.01% |
| 2017-12-31 | ₩374.73 Billion | +34.99% |
| 2016-12-31 | ₩277.59 Billion | +2.70% |
| 2015-12-31 | ₩270.31 Billion | +27.54% |
| 2014-12-31 | ₩211.94 Billion | -10.20% |
| 2013-12-31 | ₩236.03 Billion | +14.88% |
| 2012-12-31 | ₩205.46 Billion | -16.69% |
| 2011-12-31 | ₩246.62 Billion | +28.15% |
| 2010-12-31 | ₩192.45 Billion | -12.70% |
| 2009-12-31 | ₩220.43 Billion | +3.01% |
| 2008-12-31 | ₩213.99 Billion | -0.34% |
| 2007-12-31 | ₩214.73 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Jw Holdings's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 8564615724000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₩85.65 Billion | 37.31% |
| Other Components | ₩143.90 Billion | 62.69% |
| Total Equity | ₩229.54 Billion | 100.00% |
Jw Holdings Competitors by Market Cap
The table below lists competitors of Jw Holdings ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
FACT II Acquisition Corp. Class A Ordinary Shares
NASDAQ:FACT
|
$104.93 Million |
|
457550
KQ:457550
|
$104.95 Million |
|
Eg Industries Bhd
KLSE:8907
|
$104.97 Million |
|
New Era Energy & Digital, Inc.
NASDAQ:NUAI
|
$105.02 Million |
|
Silvercrest Asset Management Group Inc
NASDAQ:SAMG
|
$104.86 Million |
|
Supermax Corporation Bhd
KLSE:7106
|
$104.83 Million |
|
Alumil Aluminium Industry S.A
AT:ALMY
|
$104.81 Million |
|
PCA Corporation
PINK:PCRDF
|
$104.77 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Jw Holdings's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 123,964,559,380 to 229,541,382,040, a change of 105,576,822,660 (85.2%).
- Net income of 62,617,686,450 contributed positively to equity growth.
- Dividend payments of 17,170,385,210 reduced retained earnings.
- Share repurchases of 5,984,334,660 reduced equity.
- Other factors increased equity by 66,113,856,080.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩62.62 Billion | +27.28% |
| Dividends Paid | ₩17.17 Billion | -7.48% |
| Share Repurchases | ₩5.98 Billion | -2.61% |
| Other Changes | ₩66.11 Billion | +28.8% |
| Total Change | ₩- | 85.17% |
Book Value vs Market Value Analysis
This analysis compares Jw Holdings's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.30x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 1.69x to 1.30x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | ₩2502.52 | ₩4220.00 | x |
| 2018-12-31 | ₩2715.27 | ₩4220.00 | x |
| 2019-12-31 | ₩2255.45 | ₩4220.00 | x |
| 2020-12-31 | ₩2204.75 | ₩4220.00 | x |
| 2021-12-31 | ₩1355.51 | ₩4220.00 | x |
| 2022-12-31 | ₩1480.61 | ₩4220.00 | x |
| 2023-12-31 | ₩1715.63 | ₩4220.00 | x |
| 2024-12-31 | ₩3247.67 | ₩4220.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Jw Holdings utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 27.28%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 7.05%
- • Asset Turnover: 0.71x
- • Equity Multiplier: 5.45x
- Recent ROE (27.28%) is above the historical average (6.88%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2009 | 0.96% | 0.19% | 0.78x | 6.58x | ₩-9.75 Billion |
| 2013 | 16.91% | 3.36% | 0.52x | 9.63x | ₩7.28 Billion |
| 2014 | -11.41% | -1.91% | 0.55x | 10.81x | ₩-20.53 Billion |
| 2015 | 0.17% | 0.03% | 0.58x | 10.44x | ₩-10.19 Billion |
| 2016 | -7.43% | -1.27% | 0.57x | 10.27x | ₩-20.32 Billion |
| 2017 | 32.24% | 7.90% | 0.51x | 8.06x | ₩37.26 Billion |
| 2018 | 12.74% | 3.19% | 0.57x | 7.02x | ₩4.99 Billion |
| 2019 | -22.36% | -4.60% | 0.58x | 8.31x | ₩-48.40 Billion |
| 2020 | 7.30% | 1.37% | 0.70x | 7.65x | ₩-3.94 Billion |
| 2021 | -2.98% | -0.35% | 0.74x | 11.43x | ₩-12.10 Billion |
| 2022 | 20.70% | 2.56% | 0.75x | 10.82x | ₩11.45 Billion |
| 2023 | 15.35% | 2.05% | 0.79x | 9.49x | ₩6.63 Billion |
| 2024 | 27.28% | 7.05% | 0.71x | 5.45x | ₩39.66 Billion |
Industry Comparison
This section compares Jw Holdings's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $185,563,423,740
- Average return on equity (ROE) among peers: 1.60%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Jw Holdings (096760) | ₩567.12 Billion | 0.96% | 1.17x | $104.88 Million |
| Dongwha Pharm.Co.Ltd (000020) | $229.73 Billion | 2.15% | 0.36x | $75.32 Million |
| Yuhan Corp. (000100) | $323.58 Billion | 10.19% | 0.72x | $4.21 Billion |
| Yuyu Pharma Inc (000227) | $128.69 Billion | -1.72% | 0.50x | $26.44 Million |
| Ildong Holdings Co Ltd (000230) | $66.98 Billion | 10.88% | 1.80x | $49.55 Million |
| Samil Pharm (000520) | $62.87 Billion | 0.00% | 0.77x | $110.58 Million |
| Donga Socio Holdings (000640) | $328.69 Billion | 10.58% | 1.17x | $206.35 Million |
| Jw Pharmac (001060) | $223.83 Billion | 0.28% | 1.65x | $278.34 Million |
| JW Pharmaceutical Corp (001067) | $265.44 Billion | 13.94% | 1.43x | $489.75 Million |
| Samsung Pharm (001360) | $77.58 Billion | -31.98% | 0.20x | $65.82 Million |
| Ahn-Gook Pharmaceutical Co. Ltd (001540) | $148.25 Billion | 1.71% | 0.47x | $27.39 Million |